MGMT and glioblastoma: There is no “one-size-fits-all.” Multivariate analyses that also include the IDH mutation status, MGMT promoter methylation status and Verhaak GBM subtypes may corroborate independent prognostic predictors rather than being an epiphenomenon of established prognostic markers.